These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19486222)
1. Malignancy after heart transplantation: analysis of 24-year experience at a single center. Yagdi T; Sharples L; Tsui S; Large S; Parameshwar J J Card Surg; 2009; 24(5):572-9. PubMed ID: 19486222 [TBL] [Abstract][Full Text] [Related]
2. Cancer After Heart Transplantation: A 25-year Single-center Perspective. Van Keer J; Droogné W; Van Cleemput J; Vörös G; Rega F; Meyns B; Janssens S; Vanhaecke J Transplant Proc; 2016; 48(6):2172-7. PubMed ID: 27569966 [TBL] [Abstract][Full Text] [Related]
3. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer. Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250 [TBL] [Abstract][Full Text] [Related]
4. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience. Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001 [TBL] [Abstract][Full Text] [Related]
5. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients. Kang W; Sampaio MS; Huang E; Bunnapradist S Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396 [TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501 [TBL] [Abstract][Full Text] [Related]
7. Incidence of malignancies in cardiac allograft recipients - a single-center experience. Sobieszczańska-Małek M; Komuda K; Piotrowska M; Korewicki J; Małek G; Leszek P; Zieliński T Ann Transplant; 2013 Mar; 18():88-94. PubMed ID: 23792507 [TBL] [Abstract][Full Text] [Related]
8. Cancer incidence and survival in kidney transplant patients. Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153 [TBL] [Abstract][Full Text] [Related]
9. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661 [TBL] [Abstract][Full Text] [Related]
10. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349 [TBL] [Abstract][Full Text] [Related]
11. Periocular Skin Cancer in Solid Organ Transplant Recipients. Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170 [TBL] [Abstract][Full Text] [Related]
12. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553 [TBL] [Abstract][Full Text] [Related]
13. De Novo Malignant Neoplasms in Renal Transplant Patients. Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524 [TBL] [Abstract][Full Text] [Related]
14. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126 [TBL] [Abstract][Full Text] [Related]
15. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091 [TBL] [Abstract][Full Text] [Related]
16. Cancer of the head and neck region in solid organ transplant recipients. Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129 [TBL] [Abstract][Full Text] [Related]
17. Pretransplant malignancy as a risk factor for posttransplant malignancy after heart transplantation. Yoosabai A; Mehta A; Kang W; Chaiwatcharayut W; Sampaio M; Huang E; Bunnapradist S Transplantation; 2015 Feb; 99(2):345-50. PubMed ID: 25606783 [TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654 [TBL] [Abstract][Full Text] [Related]
19. A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population. Higgins RS; Brown RN; Chang PP; Starling RC; Ewald GA; Tallaj JA; Kirklin JK; George JF J Heart Lung Transplant; 2014 May; 33(5):478-85. PubMed ID: 24630406 [TBL] [Abstract][Full Text] [Related]
20. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients. Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]